PHOTONIS is a multinational high-technology group, with more than 40 years of experience in manufacturing, sales, and innovation, specializing in charged particle and photon sensor technology. The group operates internationally in the night vision, industrial, scientific, and medical markets.
Mass spectrometry, nuclear detection, medical instrumentation, pharmaceutical safety, industrial instrumentation, and image intensification, as well as the custom design and manufacture of detectors, sensors, and ion mobility analyzers.
PHOTONIS offers a complete range of high performance scientific and medical detector products. Our market includes electron multipliers, microchannel plates, mass spectrometry fiber optics and resistive glass, advance performance time-of-flight detectors, image intensifiers, ion mobility analyzers, neutron imagers, and other related products. Our detection products are found in most of today's technology-based markets, including analytical instrumentation, medical diagnostics, chemistry, drug discovery, high-energy physics, space exploration, and scientific research. PHOTONIS is the largest supplier of standard, retrofit, and custom detectors in the mass spectrometry, residual gas analyzer, and electron microscope markets providing advanced detector designs for the highest sensitivity through superior signal collection and noise reduction.
Sturbridge, MA; Lancaster, PA; Frisco, TX; Brive, France; Roden, Netherlands.
PHOTONIS USA
660 Main Street
Sturbridge Business Park
Sturbridge, MA 01566
TELEPHONE
(508) 347-4000
FAX
(508) 347-3849
E-MAILsales@usa.photonis.com
WEB SITEwww.photonis.com
NUMBER OF EMPLOYEES
US: 150
Elsewhere: 900
YEAR FOUNDED
1937
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.